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Abstract 25 
β-defensins are small cationic proteins with potent immunoregulatory and antimicrobial 26 
activity. The numbers of genes encoding these peptides vary significantly between and within 27 
species but have not been extensively characterised in the horse. Here, we describe a 28 
systematic search of the Equus caballus genome which has identified a cluster of novel β-29 
defensin genes on chromosome 22, which is homologous to a cluster on bovine chromosome 30 
13. Close genomic matches were found for orthologs of 13 of the bovine genes, which were 31 
named equine β-defensins (eBD) 115, eBD116, eBD117, eBD118, eBD119, eBD120, 32 
eBD122a, eBD123, eBD124, eBD125, eBD126, eBD127 and eBD129. As expression of the 33 
homologous cluster in the bovine was limited to the reproductive tract, tissue sections were 34 
obtained from the testis, caput, corpus, and cauda epididymis and the vas deferens of three 35 
stallions and from the ovary, oviduct, uterine horn, uterus, cervix and vagina of three mares. 36 
Using a quantitative Real-Time PCR approach each of the novel β-defensin genes showed 37 
distinct region-specific patterns of expression. Preferential expression in the caput epididymis 38 
of these novel defensins in the stallion and in the oviduct in the mare suggests a possible role 39 
in immunoprotection of the equine reproductive tract and/or fertility. 40 
 41 
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Introduction 44 
The recent availability and increasingly accurate annotation of multiple genomes from non-45 
model organisms has facilitated comparative genomic analysis which can shed light on gene 46 
evolution across divergent species, and also identify genetic variation which may explain 47 
differences in phenotype among animals. The evolution of immune genes is of particular 48 
interest and the lineage-specific expansion of antimicrobial peptide gene families across farm 49 
animal species holds promise for targeted breeding or improved intervention strategies 50 
(Bruhn et al., 2011). Multiple gene duplication events and subsequent sequence 51 
diversification in the mammalian lineage has resulted in a large family of defensin peptides 52 
with divergent amino acid sequence which are usually classified on the basis of their tertiary 53 
structure (Bauer et al., 2001). Mammalian defensins are a large family of cationic cysteine-54 
rich antimicrobial peptides (AMPs) with molecular masses ranging from 2 to 6 kDa and can 55 
be classified into three subfamilies; α-, β-, and θ-defensins, identified by their specific 56 
intermolecular disulfide-bond pattern, and cysteine positioning (Bruhn et al., 2009b, Davis et 57 
al., 2004). α -defensins are characterised by having disulfide bonds between cysteines 1-6, 2-58 
4, and 3-5. In contrast, β-defensins are comprised of disulphide linkages between cysteine 59 
residues 1-5, 2-4, and 3-6 (Davis et al., 2004, Ganz, 2003). The three disulfide bonds 60 
positioned in a predictable manner forms the defensin motif, which is conserved across 61 
peptides and species (Semple et al., 2003). θ-defensins are rare peptides discovered in the 62 
rhesus macaque and are present only in primates, the single θ-defensin gene in humans is 63 
truncated by a stop codon creating a pseudogene (Tran et al., 2008). 64 
β-defensin genes have been found in most vertebrate genomes and encode small, cationic 65 
proteins produced by phagocytic cells, lymphocytes, and the epithelial cell lining of the 66 
gastrointestinal and genitourinary tracts, the tracheobronchial tree, and keratinocytes 67 
(Schneider et al., 2005). Given their antimicrobial activity (Choi et al., 2012, Narciandi et al., 68 
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2011, Schöniger et al., 2013), β-defensins are traditionally regarded as vital effector 69 
molecules of the innate immune system (Davis et al., 2004, Ganz, 2003, Ganz, 2004). 70 
However, members of this gene family have also been shown to have immunoregulatory and 71 
chemotactic activity (Bowdish et al., 2005). Recent studies in other species have shown that 72 
β-defensins are expressed by the reproductive tissues in mice, rats and cattle (Com et al., 73 
2003, Cormican et al., 2008), which has led to speculation about a potential role in the 74 
protection of the reproductive tract against pathogens, or in the regulation of fertility. A 75 
cluster of 19 novel bovine β-defensin genes were shown to be expressed in a region-specific 76 
manner across the male and female reproductive tracts, suggesting a role in bovine 77 
reproduction (Narciandi et al., 2011). Evidence for β-defensin mediated regulation of fertility 78 
has been supported by recent findings in primates – Macaque sperm have been shown to be 79 
coated with β-defensin 126 (BD126), which facilitates their passage through cervical mucus 80 
in vitro (Tollner et al., 2008b). Similarly the same peptide is thought to contribute to 81 
capacitation (Tollner et al., 2009), enabling sperm-binding to oviductal epithelia (Tollner et 82 
al., 2008a), as well as the prevention of immunorecognition in the female tract (Yudin et al., 83 
2005a). Finally, polymorphisms in human BD126 are known to contribute to sub-fertility in 84 
males (Tollner et al., 2011a) and a recent study has shown that β-defensin gene knock-out 85 
male mice are completely infertile (Zhao et al., 2011). 86 
Since the publication of the equine genome in 2007, 38 α-defensins have been identified, all 87 
of which were shown to be expressed in the gastrointestinal tract (Bruhn et al., 2009a, Bruhn 88 
et al., 2009b) and twenty of which have the potential to code for functional proteins (Bruhn et 89 
al., 2009b). The retention of protein-coding α-defensin genes identifies the horse genome as 90 
distinct from members of the artiodactyl order, which have not retained α-defensin genes 91 
(Fjell et al., 2008, Lynn and Bradley, 2007). Very limited characterisation of the β-defensin 92 
gene family has been performed in the horse (for review see: Bruhn et al., 2011). The first 93 
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gene was discovered in 2004 (DEFB1; Davis et al., 2004) and expression was documented 94 
across a range of tissues, including the small intestine, liver, heart and uterus (Schöniger et 95 
al., 2013). Some genes show more specific patterns of expression including β-defensin 103, 96 
reported to be exclusively expressed in the tongue of the horse. Subsequent analysis 97 
identified additional β -defensin family members (Looft et al., 2006), and although sequence 98 
validation was not performed, the synteny of those β -defensins was shown to be similar to 99 
genomes from other species. The aim of this study was to use a comparative genomics 100 
approach to search for evolutionary orthologs for a recently discovered cluster of bovine β-101 
defensin genes in the equine genome.  102 
 103 
Materials and Methods 104 
Bioinformatic Identification of Equine Beta Defensin Ortholog 105 
Homology searches with the Basic Local Alignment Search Tool (BLAST) (Altschul et al., 106 
1990) were performed using gene sequences for the 19 known bovine β-defensins on 107 
chromosome 13, to find homologous genes in the equine genome (Version Broad equ/Cab2 108 
Sep 2007). The bioinformatic tool, BLAST-Like Alignment Tool, (BLAT) was used to 109 
determine the chromosomal position of equine genes homologous to other mammalian β-110 
defensin genes. BioEdit software was used to perform multiple sequence alignments between 111 
the equine and bovine protein sequences. To annotate the putative β-defensin-encoding 112 
sequences identified from our analysis, a phylogenetic analysis was performed using MEGA 113 
software, version 5.2 (Ram et al., 2014). Bootstrap resampling was carried out 1,000 times. 114 
Phylogenetic analysis was performed to investigate the evolutionary relationships among the 115 
thirteen novel β-defensins in the equine and their bovine homologs.  Equine β-defensin genes 116 
were annotated on the basis of sequence similarity and phylogenetic relationships to 117 
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previously described β-defensins in cattle to maintain consistency in the comparative analysis 118 
of β-defensins with other species. Nucleotide sequences were aligned using T-coffee 119 
(Notredame et al., 2000) and annotated using Jalview (Waterhouse et al., 2009). 120 
 121 
Reproductive Tissue Collection 122 
Reproductive tract tissues including testis, the different segments of epididymides (caput, 123 
corpus, cauda) and vas deferens (Figure 1) were collected from 2-4 years old sexually mature 124 
Connemara stallions (n=3) immediately post-castration. Reproductive tract tissues including 125 
the ovary, oviduct, uterine horn, uterine corpus, cervix, and vagina (Figure 1) in the luteal 126 
phase (confirmed by the presence of a corpus luteum; n=3) were retrieved from 5-8 year old 127 
Connemara non-pregnant mares (n=3) post-mortem, at a local abattoir, within 20 min of 128 
slaughter. All tissue samples were placed in RNAlater (Qiagen, Crawley, UK), held at 4°C 129 
overnight, and subsequently stored at -20°C.  130 
 131 
RNA Extraction and cDNA Synthesis  132 
Total ribonucleic acid (RNA) was extracted from all tissues using a homogenizer to disrupt 133 
cells in the RLT buffer, supplied with the RNeasy® mini kit (Qiagen, Crawley, UK), 134 
according to the manufacturer’s instructions. All samples were DNA digested to remove 135 
genomic DNA using Qiagen’s on-column DNase, and eluted with water. RNA quantity was 136 
assessed using a Nanodrop spectrophotomer (Thermo Fisher Scientific, Waltham, MA, 137 
USA), while the quality was determined with the use of an Agilent Bioanaylser (Agilent 138 
Technologies, California). cDNA was synthesised using an Applied Biosystems cDNA 139 
reverse transcription kit (Life Technologies, California), and an Eppendorf Mastercycler 140 
(Eppendorf, Hamburg).  141 
 142 
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Primer Design, qRT-PCR and Data Analysis 143 
Nucleotide sequences were retrieved from the University of California, Santa Cruz (UCSC) 144 
Genome Browser, and entered into Primer3 (Rozen and Skaletsky, 2000) to determine the 145 
best nucleotide sequence of both a forward and reverse primer, for each gene (Table 1). 146 
Primers were designed, where possible, to be intron spanning and commercially synthesised 147 
(Sigma Aldrich, MO, USA). Equine β-defensin 132 was not amplified, as only one exon was 148 
found in the genome sequence; and therefore, an intron-spanning primer could not be 149 
designed. Quantitative real time polymerase chain reaction (qRT-PCR) was performed using 150 
a 20 µL reaction mix containing: 10 µL SYBR green PCR Master Mix (Invitrogen Ltd, 151 
Paisley, UK), 2.5 µL primer and dH2O mix, 5.5 µL dH2O, and 2 µL sample. Plates were run 152 
in an ABI 7500 Fast Thermocycler. The cycle parameters were as follows; UNG activation 153 
was run for 2 minutes at 50°C, DNA polymerase activation for 10 minutes at 95°C, the melt 154 
cycle was run for 15 seconds at 95°C, and the annealing/extending cycle for 1 minute at 155 
60°C. A no-template control (NTC) was run in each 96-well plate to confirm the absence of 156 
contamination and all products were run on an agarose gel to confirm the presence of a single 157 
PCR product, of the correct size. A 1% agarose gel was stained with 5 µL ethidium bromide, 158 
while each 20 µL PCR product was stained with 3 µL blue tracking dye. Three microlitres of 159 
1kb ladder was used, while 5 µL of sample was added into each well, and gels were run at 160 
100mV, for 40 min. Gel electrophoresis images were acquired using a FluorChem system 161 
(Alpha Innotech, CA, USA). Levels of gene of interest expression were determined using 162 
fold changes, calculated using the ΔCt (cycle threshold) method (Livak and Schmittgen, 163 
2001), compared with the average of the two reference genes-GAPDH and ACTβ. 164 
Normalising gene expression to multiple reference genes in order to give a more reliable 165 
baseline for the calculation of relative gene expression using qRT-PCR is common practice 166 
especially when small changes in gene expression are being reported (Vandesompele et al., 167 
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2002).  Gene expression data among the tissues (within gender) were examined for normality 168 
of distribution, transformed where appropriate using an arctan transformation, and analysed 169 
using analysis of variance in the Statistical Package for the Social Sciences (SPSS, Version 170 
21.0; IBM, USA). Post-hoc tests were carried out using the Bonferroni correction, and a P 171 
value < 0.05 was considered statistically significant. 172 
 173 
Results 174 
Discovery of Novel β-defensins in the Equine Genome 175 
Of the 19 novel β-defensin genes recently reported in the bovine, thirteen were found to be 176 
present on chromosome 22 in the equine genome (Table 1). Close genomic matches were 177 
found for orthologs of the bovine genes, which were named equine β-defensins (eBD) 115, 178 
eBD116, eBD117, eBD118, eBD119, eBD120, eBD122a, eBD123, eBD124, eBD125, 179 
eBD126, eBD127 and eBD129. Incomplete sequences were retrieved for eBD119 and 180 
eBD132, which were found to only have one conserved exon. No close matches to bovine β-181 
defensins bBD121, bBD122, bBD125a, bBD128 or bBD142 were detected in the equine 182 
genome. It should be noted that bBD122 and bBD122A are 75% identical in their amino acid 183 
composition resulting from duplication and subsequent divergence of the bovine 122 locus, 184 
all within the second exon. eBD122a is the ortholog of BBD122a, and the similarity between 185 
these peptides is 65%. 186 
 187 
Bioinformatic Analysis 188 
Multiple sequence analysis was performed on novel defensin sequences with a complete 189 
second exon. Despite the high sequence variation between genes, the conserved cysteine 190 
9 
 
signature was clearly visible in each (Figure 2). Phylogenetic analysis revealed two semi-191 
distinct groups with a bootstrap value of 22, indicating 78% resemblance (Figure 3). 192 
Likewise, a bootstrap value of 100 indicates that these genes map to one another 100% of the 193 
time (through resampling of the data) and therefore, due to the very high degree of sequence 194 
similarity they are definitely orthologs. The smaller of the two groups consisting of eBD117, 195 
eBD125, eBD126, and eBD127; whilst the larger group was made up of the remaining eight 196 
genes; eBD115, eBD116, eBD118, eBD119, eBD120, eBD122a, eBD123, eBD124, and 197 
eBD129.  198 
 199 
Expression of Novel Defensins Across Equine Reproductive Tissues 200 
Expression of the twelve of the novel bovine β-defensin genes was investigated in a panel of 201 
reproductive tissues collected post-mortem from a panel of healthy stallions and mares 202 
(Figure 1), eBD118 is not shown. Expression profiles for a selected panel of genes (which 203 
had the most animal to animal variation) in various tissues across the stallion and mare 204 
reproductive tracts were generated using qRT-PCR and are shown in Figures 4 and 5, 205 
respectively. Expression of eBD116 was lower for all three stallions in the testes than in the 206 
remaining 4 regions of the reproductive tract (P < 0.01). The expression profile for this gene 207 
was similar among stallions and highest expression was detected in the corpus of the 208 
epididymis. In contrast, expression of eBD117 showed more divergence among stallions, 209 
with high relative expression in the testes. eBD117 expression was consistently higher in 210 
samples from stallion 1, than stallion 2 and 3. Gene expression in the caput of the epididymis 211 
was over 1000 fold higher than the reference genes in this tissue, making eBD117 the highest 212 
expressed gene in this analysis (Figure 4). Clear differences between stallions were apparent 213 
in the eBD120 expression profile, where for stallion 1, expression was highest in the corpus 214 
of the epididymis. Expression of this gene was at its lowest in the corpus for stallions 2 and 3. 215 
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Expression for eBD125 was consistent between stallions and showed lowest expression in the 216 
vas deferens. Variability of eBD126 was seen among the corpus epididymis samples of the 217 
three stallions, while the expression was relatively homogeneous across the other sections of 218 
the stallion reproductive tract (qRT-PCR data not shown). 219 
 In general, expression in the mare reproductive tract was lower than in the stallion 220 
reproductive tracts and also exhibited higher inter-animal variation (Figure 5). Mare 2 221 
showed consistently lower expression across most genes than mare 1 and 3. Similarly to that 222 
detected in the stallion tract, eBD117 was the highest expressed gene in this analysis. 223 
Expression was over 200 fold higher than the reference genes in the oviduct of mare 1 and 3. 224 
The oviduct and the uterus were found to be the predominant sites of β-defensin expression in 225 
the mare, with the exception of eBD119, which had significantly lower expression than all 226 
other genes, in all regions. Unlike the stallion, eBD116 had notably lower expression in the 227 
mare’s reproductive tract, in particular in the cervix and uterine horn in the mare, as did 228 
eBD126, which displayed extremely low expression in the ovary and uterine horn. Equine β-229 
defensin 115 and 117 had differential regional expression across the mare reproductive tracts. 230 
Both were highly expressed in the common body of the uterus of the mare; however, they had 231 
a much lower expression in the anatomically adjacent uterine horn.  232 
Some β-defensins (eBD129 and eBD122a) were found to be homogeneously 233 
expressed across the genital tract in both stallions and mare, whereas, others (eBD115 and 234 
eBD116) were more highly expressed in the stallion reproductive tract (P < 0.01). EBD119 235 
was found to be expressed at a low level across all tissue samples (both mare and stallion), 236 
while eBD117 was shown to have the overall highest expression in the stallion (P < 0.01). 237 
Defensin-like 2 and 3 (DEFL 2 & 3) were expressed at low levels in the reproductive tracts of 238 
both the mare and the stallion. In general, highest expression for the majority (10 of 13) of 239 
these genes was in the caput epididymis (Figure 6).  240 
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 241 
Discussion  242 
The advent of more completely annotated genomes from farm animal species is facilitating 243 
gene discovery at an unprecedented level. As immune genes with potent antimicrobial and 244 
immunomodulatory functions, β-defensins hold significant interest for understanding the 245 
immune response but also in the design of novel therapeutics.  246 
The current study was designed to examine if the β-defensin genes are expressed 247 
along the reproductive tract of the mare and stallion (as they are in the bovine) and to 248 
demonstrate the variation between animals in selected EBDs. Using a comparative genomics 249 
approach, we searched the Equus caballus genome for homologs of 19 recently discovered 250 
bovine β-defensins. Thirteen novel genes were found on chromosome 22 in the equine 251 
genome and bioinformatic analysis revealed that the equine defensins are present in a similar 252 
syntenic sequence to those of the bovine. Orthologs for the remaining 6 genes were not found 253 
which may reflect the loss of these genes over the 100 million years of evolution since the 254 
horse and cow last shared a common ancestor.  255 
Multiple sequence alignment showed the conservation of the characteristic six 256 
cysteine residues (Ganz, 2003) in the equine β-defensin genes. Phylogenetic analysis of these 257 
equine genes in conjunction with their bovine orthologs (Narciandi et al., 2013), show a high 258 
degree of sequence similarity which suggests functional conservation of these genes over the 259 
course of evolution. The percentage of sequence identity ranged from 37% (BD118) to 95% 260 
(BD119). The ortholog pairs generally cluster together with high boot-strap values but the 261 
evolutionary relationships, among the genes was quite flat and unstructured, as expected from 262 
such short input sequences.  263 
Expression analysis of β-defensins in the reproductive tracts of other species 264 
demonstrated quantitative variation in gene expression in various sections of the genital tract, 265 
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thus suggesting that site-specificity of gene expression may reflect differences in the 266 
biological role of these β-defensins (Com et al., 2003, Jelinsky et al., 2007, Zhou et al., 267 
2004). All novel equine genes examined in this study were found to be expressed across the 268 
reproductive tracts of all three stallions and the basal expression of these β-defensin genes in 269 
the absence of infection suggests that in addition to being antimicrobial and capable of 270 
protecting sperm from infections, these molecules may constitute an essential component in 271 
maintaining the normal reproductive process. The high expression found in the caput 272 
epididymis for all genes, in all stallions, and the low gene expression patterns found in the 273 
vas deferens, for the majority of the genes (8 out of 13) in stallions, is in agreement with 274 
studies which suggest that initiation of sperm maturation, and the induction of progressive 275 
motility are associated with β-defensin absorption, which occurs in the epididymis of humans 276 
(Tollner et al., 2011b), macaques (Tollner et al., 2008b), rats (Zhou et al., 2004), mice 277 
(Yudin et al., 2008), pigs (Choi et al., 2012) and cattle (Narciandi et al., 2013). This 278 
consistent and high expression of β-defensins in the caput epididymis, is suggestive of a 279 
potential role in final sperm maturation for these genes.  280 
β-defensin 126 is a gene of particular interest as it has been documented to regulate 281 
human male fertility. Coating the sperm glycocalyx in humans (Tollner et al., 2011b) and 282 
macaques (Tollner et al., 2011b, Tollner et al., 2008b), DEF126 has been found to be critical 283 
for the movement of sperm through macaque cervical mucus (Tollner et al., 2008b). 284 
Furthermore, the removal of DEF126 from the sperm surface is essential for the completion 285 
of capacitation in the female reproductive tract of macaques (Tollner et al., 2009, Yudin et 286 
al., 2003). This is essential for the biochemical events leading to the recognition, and 287 
subsequent fertilisation of the oocyte in macaques (Tollner et al., 2004). Following treatment 288 
of macaque sperm, with anti-DEF126 antibodies Tollner et al., demonstrated that sperm had 289 
significantly reduced ability to penetrate cervical mucus (Tollner et al., 2008b), while upon 290 
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add back of DEF126, penetration ability was restored. Furthermore, humans that are 291 
homozygous for the DEF126 gene (del/del) have been shown to have reduced fertility; more 292 
specifically this mutation causes reduced mucus penetration ability in sperm (Tollner et al., 293 
2011b). In this study, eBD126 had relatively homogenous expression across the stallion 294 
genital tract, with the exception of the corpus epididymis, which was more varied, suggesting 295 
that it has a similar role in sperm maturation as that described in other species (Tollner et al., 296 
2008a, Tollner et al., 2008b, Yudin et al., 2005a, Zhou et al., 2004). eBD117 was found to 297 
have the overall highest expression across all reproductive tissue samples in both the stallion 298 
and mare. Interestingly, in the cow, the expression of the β-defensin gene cluster is limited to 299 
the reproductive tract, with the exception of eBD117 (Narciandi et al., 2011).  300 
Based on their location in the testis and epididymis, and in consideration of recent and 301 
associated studies (Tollner et al., 2009, Tollner et al., 2008a), β-defensins could potentially 302 
mediate the binding of the sperm to the equine female oviductal epithelia. In addition, 303 
defensins could be important for sperm maturation in the male tract: this process is known to 304 
occur by the attachment of multiple proteins (DEFB126, cAMP; Yudin et al., 2003, Yudin et 305 
al., 2005b) to the sperm surface during its transit through the epididymis (Acott and Hoskins, 306 
1981, Narciandi et al., 2011, Yudin et al., 2003). Alternatively the regional distribution of the 307 
β-defensins could be explained by the various groups targeting specific pathogens only 308 
present in that region, or to prevent infection in the female reproductive tract following 309 
mating (Sorensen et al., 2003), however, the lack of inflammation or infection in tissues 310 
sampled in this study suggests a role outside that of solely defence. However, it has been 311 
demonstrated in pregnant women that there is an increase in expression of β-defensins in the 312 
amniotic fluid of women with intrauterine infection, and preterm labour (Mitchell et al., 313 
2013). Interestingly, women with bacterial vaginosis, a condition in humans similar to 314 
endometritis in the mare, had an up regulation of β-defensins in the uterine environment, 315 
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where the concentration of human β-defensin and bacteria were positively correlated 316 
(Mitchell et al., 2013). Similar findings have also been reported in hens, where CpG-ODN 317 
derived from microbes upregulates the expression of IL1B and IL6 by interaction with TLR21 318 
and then IL1B induces AvBD1 and -3 to prevent infection in the vagina (Sonoda et al., 2013). 319 
Finally, the annotation of the equine genome is at an early stage and more thorough 320 
characterisation may show that some of these β-defensin genes are actually alternatively 321 
spliced isoforms rather than distinct genes, as has been shown for orthologs in the human 322 
genome (Radhakrishnan et al., 2005).  323 
 324 
Conclusion 325 
In conclusion, this study is the first to genomically identify and validate the 326 
expression of a novel β-defensin gene cluster in equine reproductive tract. The evolutionary 327 
orthologs of these genes have been shown to play a pivotal reproductive-immunobiological 328 
role, across a range of species including mice, macaques and men. Shedding light on the 329 
evolution of these pleiotropic molecules, these genes can now be targeted for population 330 
genetic analysis, to identify functional polymorphisms that may contribute to higher fertility 331 
in individual horses, and between horse breeds.  332 
This could help generate new assisted reproductive technologies, as well as the 333 
development of alternative treatments, for conditions such as post breeding induced 334 
endometritis, which is one of the largest causes of infertility in mares. Sequence variants in 335 
these genes could explain some of the phenotypic variation in susceptibility to infection in 336 
mares. A study with a much higher number of animals now needs to be done to investigate if 337 
variation in the β-defensin expression can explain differential susceptibility to infection in 338 
mares. 339 
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 495 
Table 1 Oligonucleotide sequences for primers of the genes used in this study, and the 496 
genomic coordinates of the defensin genes (UCSC version equCab2). 497 
Gene 
symbol 
Forward primer (5'- 3') Reverse primer (5'- 3') Genomic Co-ordinates 
GAPDH AAGGTCATCCCTGAGCTGAA TGGAAGAGTGGGTGTCACTG NM_001163856.1 
ACTb GATCTGGCACCACACCTTCT GAGTCCATCACGATGCCAGT NM_001081838 
DEFL2 CCTTCTCATCTTTGTTGTCCTC TTCCTCCTCAGGCAGACACT AM039964 
DEFL3 CTTGTGTGTCTCATCCAGACG CGTGTTTTCTCCCCGTTTT AM039964 
eBD115 TATGCTGCTGGATCATTCCTC GTTACCTGGGGAAGCCTGA chr22:22,315,338-22,510,961 
eBD116 CCATCCTTCTGATGCTGGTT TTCTGCACATGCCTTGGTAA chr22:22,391,758-22,396,465 
eBD117 GACATTGCAGGAAAGACTGC TGGATTGGTCTGTGTGGTTG chr22:22,440,878-22,440,997 
eBD119 CTTTCTGGCCATGGAACCAG TGTTACCCATGCACTGAAGG chr22:22,475,857-22,475,916 
eBD120 CGGTTGGTGTGCAAAGATGA CCAGGGGAGTTCTCCATCAA chr22:22,474,538-22,474,687 
eBD122a GCTGGAATCTTCATGGCACC CAGTGGTAAATTCGGCTGGA chr22:22,510,961-22,511,080 
eBD123 ACCCGAAAATGCTGGAATCT 
 
TGGTACTTGGGCTTCACACA chr22:22,546,361-22,546,486 
eBD124 AATTCAAACGGTGCTGGAAG 
 
TGAGTCCGTAGGGGAGACAG chr22:22,559,089-22,562,585 
 
eBD125 GCTGGCTGGGAAGTCAAA 
 
AATCCTCCTCACTCGTTATGG chr22:22,264,333-22,270,987 
eBD126 GGTATGTGAGAAAGTGTGGAAACA TCTTTGCTGCACATGCCAGT chr22:22,207,554-22,207,679 
eBD127 ACTTAAGAAATCGTGGGGTGA GTCATTGGCTTTGGACGTGT chr22:22,192,358-22,192,582 
eBD129 
 
 
TGGGGAGATGCAAAGACCAT ACCGGTGCTTTTGATTTTGGA chr22:22,136,194-22,138,292 
 498 
 499 
 500 
 501 
 502 
 503 
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Figure 1: Sites of tissue sample collection. The sites of tissue collection in the reproductive 518 
tract of the stallion (A) and mare (B). Note that the reproductive tracts are not represented to 519 
scale.  520 
 521 
 522 
 523 
 524 
 525 
 526 
A B. 
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Figure 2: Multiple sequence alignment of the equine β-defensins. Multiple sequence 527 
alignment showing the conserved cysteine residues for the novel equine β-defensins (shaded). 528 
[eBD115, eBD119 and eBD132, genes were excluded from the figure, as only first exon 529 
sequences had been  recovered]. 530 
 531 
 532 
Figure 3: Phylogenetic tree between the between the thirteen novel β-defensins in the equine 533 
genome with the bovine orthologs. Phylogenetic tree showing the evolutionary relationship 534 
between the thirteen novel β-defensins in the equine genome with the bovine orthologs. The 535 
numbers at the nodes are % bootstrap values. 536 
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 537 
 538 
Figure 4: Expression of four representative β-defensins in the reproductive tracts of 3 539 
stallions. Variation in expression of selected equine β-defensin genes (eBD116, eBD117, 540 
eBD120 and eBD125), across the reproductive tracts of 3 stallions. Expression was 541 
normalised to the average of GAPDH and ACTβ gene expression (represented by 0 on graph). 542 
Tissue sections identified as T, testis; E-CT, caput epididymis; E-CS, corpus epididymis; E-543 
CL, cauda epididymis; VD, vas deferens. 544 
 545 
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 546 
Figure 5: Expression of four representative β-defensins in the reproductive tracts of 3 mares. 547 
Variation in expression of selected equine β-defensin genes (eBD115, eBD117, eBD119 and 548 
eBD127), across the reproductive tracts of 3 mares. Expression was normalised to the average 549 
of GAPDH and ACTβ gene expression (represented by 0 on graph). Tissue samples 550 
identified as OV, ovary; OvD, oviduct; UH uterine horn; UT, uterine corpus; CX, cervix and 551 
VG, vagina. 552 
 553 
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 554 
Figure 6: Tissue expression profiles of novel equine β-defensins shown using gel 555 
electrophoresis following qRT-PCR. Tissue expression profiles of novel equine β-defensins, 556 
 T      E-CT    E-CS     E-CL    VD      OV     OVD     UH       UT       CX       VG   
NTC 
25 
 
DEFL 2 & 3, and reference genes (ACTβ and GAPDH) across the stallion and mare 557 
reproductive tracts, shown using gel electrophoresis following qRT-PCR. Results shown are 558 
from a representative stallion (lanes 1-5; T, testes; E-CT, caput epididymis; E-CS, corpus 559 
epididymis; E-CL, cauda epididymis and VD, vas deferens) and a representative mare (Lanes 560 
6-11; OV, ovary; OvD, oviduct; UH, uterine horn; UT, uterine corpus; CX, cervix; VG, 561 
vagina). A no-template control (NTC) is shown in lane 12. 562 
 563 
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